Australia markets closed

Zura Bio Limited (ZURA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.49-0.15 (-2.66%)
At close: 04:00PM EDT
5.53 +0.04 (+0.73%)
Pre-market: 07:13AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 349.62M
Enterprise value 349.97M
Trailing P/E 8.45
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.73
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.14
52-week change 31.10%
S&P500 52-week change 326.14%
52-week high 313.00
52-week low 32.00
50-day moving average 33.82
200-day moving average 34.68

Share statistics

Avg vol (3-month) 3325.99k
Avg vol (10-day) 3213.88k
Shares outstanding 563.68M
Implied shares outstanding 663.68M
Float 814.86M
% held by insiders 139.15%
% held by institutions 149.93%
Shares short (15 May 2024) 4721.37k
Short ratio (15 May 2024) 42.55
Short % of float (15 May 2024) 41.62%
Short % of shares outstanding (15 May 2024) 41.13%
Shares short (prior month 15 Apr 2024) 4428.37k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-58.67%
Return on equity (ttm)-104.43%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-60.18M
Diluted EPS (ttm)0.65
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)89.82M
Total cash per share (mrq)2.06
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.17
Book value per share (mrq)1.40

Cash flow statement

Operating cash flow (ttm)-16.78M
Levered free cash flow (ttm)-33.42M